Digipharm


DIGIPHARM



Digipharm brings together industry expertise, mature concepts and revolutionary blockchain technologies to facilitate the transformation of health care into a value-based approach.

The cost of spiral health combined with resource constraints has resulted in an unrelenting burden on the health system. Negotiations should be made, patients at risk of rejected innovative treatments and there are still barriers to reimbursement for producers.

Digipharm passed the limitations of infrastructure to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of an unprecedented platform of evidence and the ability to reward patients for the contribution of their data.


Our vision

To pioneer the delivery of sustainable and value-based health services,

generation of innovative evidence and patient empowerment across the health care industry.







The Future of Health Care

  • Values Based Care
Health care systems around the world today are threatened by unique challenges in our day; unsustainable spending, an aging population and an increasing prevalence of chronic diseases. Value-based health concepts propose that payments for health care should be linked to the quality of care and benefits it provides; switch from 'cost for service' to 'cost-for-performance' replacement model.
  • Innovative Price
Innovative pricing solutions such as value-based pricing offer an increasingly dynamic solution to address the uncertainty surrounding the relative costs of treatment relative to patient outcomes. Such mechanisms reward manufacturers and providers for improving patient outcomes, incentivize innovation and drive the transition to patient-centered healthcare.
  • Generation of Pioneer Evidence
Innovative proof generation solutions are required to meet relevant, timely and quality data needs to inform optimized value-based health services delivery. Avoiding the use of static or retrospective data will open the horizons for superior forecasting, confidence in decision making and global oversight related to current developments in increasingly dynamic industries such as healthcare.


The Digipharm Difference


Elimination of Obstacles
While value-based health services provide solutions to the various problems faced by the health care system, the use of a broad-based value-based approach has been hampered by the limitations of current health information system infrastructure, administrative burden of implementation and fragmentation of health care delivery and patient outcome data.





Patient Empowerment
Digipharm is a strong believer in empowering patients with the care and ownership of their personal data. Patients will be given incentives to share and contribute their health-related data to inform decision-making and health-related research.





Blockchain Technology
The Digipharms solution will facilitate and accelerate paradigm shifts to value-based healthcare and patients using 'smart contracts' and blockchain technologies. Utilizing blockchain technology for the Digipharms platform promotes the development of an ubiquitous, transparent and secure decentralized health information infrastructure.


Our Excellence Solutions

Reimbursement will remove infrastructure barriers and automate the implementation of value-based pricing agreements, no matter how complex, on fully independent global platforms; encourage personal health technology change on a fee for performance basis for the benefit of patients, payers and producers.

  • Speed up access to high cost therapies

  • Encourage innovation

  • Drastically reduce administrative costs

Insight is a place of real evidence of a 'live' world and allows the utilization of real-world evidence (RWE) as soon as it is available. The availability of 'live' RWE will provide stakeholders with real-time intelligence that they can inform decision-making and product development throughout the drug's lifecycle.

  • Incentives for patients to contribute data

  • Significant cost savings compared to conventional RWE sources

  • Single platform for global proof


Our Team





Ahmed Abdulla

Founder/CEO



Girisha Fernando

Co-Founder/COO



Zach Daniels

CTO



Ralf Gerteis

Commercial Strategy



Alexander Sverdlov

Cybersecurity Strategy



Meredith Darden

Digital Marketing Lead



Alexey Popov

Web Development



Michael Gubert

UI/UX Design




Leon Rebolledo

Lead Architect




Rolf Günter

Legal Counsel




Bobby Kaura

Business Development



Dr. Mohamed Abdulla

Clinical Transformation




Dr. Hasham Al-Meshhedani

Patient Engagement



Ali Al-Sudani

Clinical Pharmacist




Dr. Rami Radwan

Clinical Relations




Peter Sandbach

Communications Director




Debra De Silva-Sun

HEOR & Pricing Analyst




Marko Granic

Graphic Designer


Our Advisors


Sven Möller

ICO Advisor
Swisscom Blockchain AG



Kamal Youssefi

Enterprise Blockchain Advisor
Swisscom Blockchain AG



Waldemar Scherer

Life Sciences Blockchain Advisor
Swisscom Blockchain AG



Sam Mantle

Health & Life Sciences Technology Advisor
Luxoft



Daniel Heller

PR Advisor
Partner, Farner Consulting AG



Claudio Staub

Co-Head Startup Communications
Farner Consulting AG



Anas Aman

Quality and Testing
IBM



Lloyd Jefferies

CRM Advisor
KPMG



Per-Olof Thuresson

Health Economist
Roche



Fadi Chehadah

Health Economist
NICE UK



For more information and join social media DIGIPHARM please follow some sources for reference:


===============================
Author: Mbladur

Komentar

Postingan populer dari blog ini

MOMENTUM

XYO Network

Bitnation